Mizoribine in Place of 6-Mercaptopurine for Maintenance in a Child With Relapsed NT5C2-Mutant B-Cell Acute Lymphoblastic Leukemia: A Case Report.

IF 2.4 3区医学 Q2 HEMATOLOGY

Pediatric Blood & Cancer Pub Date : 2026-10-10 DOI:10.1002/1545-5017.70763

Jiaqi Qu, Jinfeng Yang

引用次数: 0

查看原文本刊更多论文

米佐瑞滨替代6-巯基嘌呤维持复发性nt52c突变b细胞急性淋巴细胞白血病儿童1例报告

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pediatric Blood & Cancer 医学-小儿科

CiteScore

4.90

自引率

9.40%

发文量

546

审稿时长

1.5 months

期刊介绍： Pediatric Blood & Cancer publishes the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.